SCHEMBL31107241

SCHEMBL31107241

COC(=O)c1c(F)c(Cl)c(Br)c2cnn(C)c12

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 1/20 0.37
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
TP53 P04637 1/20 0.33
P2RX7 Q99572 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
EPAS1 Q99814 1/20 0.31
CLK1 P49759 1/20 0.31
TSHR P16473 2/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
BPTF Q12830 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24558296 1.00 KDM4E (0.37) KDM4EALDH1A1GAAHTTSMN1; SMN2
SCHEMBL24558219 0.85 HTT (0.33) HTTSMN1; SMN2P2RX7MEN1KMT2A
SCHEMBL24558226 0.74 KDM4E (0.34) KDM4EALDH1A1GAASMN1; SMN2MEN1
SCHEMBL25464887 0.74 PDE2A (0.33) HTR2C
SCHEMBL31107239 0.73 TSHR (0.36) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL24558302 0.73 TSHR (0.36) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL31444314 0.69 KDM4E (0.40) KDM4EALDH1A1GAASMN1; SMN2CYP1A2
SCHEMBL29851161 0.67 PDE1C (0.34) KDM4EALDH1A1GAATP53P2RX7
SCHEMBL31521427 0.66 CYP1A2 (0.48) KDM4EALDH1A1GAAHTTSMN1; SMN2
SCHEMBL31743371 0.66 SCN9A (0.42) KDM4EALDH1A1GAACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113508118-B Fused tricyclic compounds useful as anticancer agents 阿斯利康(瑞典)有限公司 2024-07-19 CN disclosed